Guardant Health director exercises 4,203 RSUs

Guardant Health director Steve E. Krognes reported equity compensation activity.

Rhea-AI Filing Summary

Guardant Health director Steve E. Krognes reported equity compensation activity. On June 17, 2026, 4,203 Restricted Stock Units fully vested in connection with the company’s 2026 Annual Meeting of Stockholders and were converted into an equal number of shares of common stock.

Following this derivative exercise, Krognes held 14,425 shares of Guardant Health common stock directly. On the same date, he also received a new grant of 2,711 Restricted Stock Units, each representing a right to receive one share of common stock that will vest in full on the earlier of June 17, 2027 or the company’s next annual stockholder meeting.

Insider Trade Summary

4,203 shares exercised/converted

Exercise 3 txns

Insider Krognes Steve E.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	4,203	$0.00	$0.00
Grant/Award	Restricted Stock Units	2,711	$0.00	$0.00
Exercise	Common Stock	4,203	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 2,711 contracts (Direct); Common Stock — 14,425 shares (Direct)

Footnotes (3)

1. F1. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
2. F2. Not applicable for Restricted Stock Units.
3. F3. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.

Key Figures

RSUs vested and exercised: 4,203 shares Common shares held after transaction: 14,425 shares New RSU grant: 2,711 units +1 more

4 metrics

RSUs vested and exercised 4,203 shares Restricted Stock Units converted to common stock on June 17, 2026

Common shares held after transaction 14,425 shares Direct ownership after RSU conversion on June 17, 2026

New RSU grant 2,711 units Restricted Stock Units granted on June 17, 2026

RSU vesting schedule Full vesting on June 17, 2027 or next annual meeting Vesting terms for 2,711-unit RSU grant

Key Terms

Restricted Stock Units, derivative security, Annual Meeting of Stockholders

3 terms

Restricted Stock Units financial

"The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Annual Meeting of Stockholders financial

"the 2026 Annual Meeting of Stockholders which was held on June 17, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Steve E. Krognes report at Guardant Health (GH)?

Steve E. Krognes reported equity compensation activity, not open-market trading. 4,203 Restricted Stock Units vested and converted into common shares, and he received a new grant of 2,711 Restricted Stock Units, all dated June 17, 2026.

How many Guardant Health shares does Steve E. Krognes hold after these Form 4 transactions?

After the June 17, 2026 vesting and conversion, Steve E. Krognes directly holds 14,425 shares of Guardant Health common stock. This figure reflects his position following the 4,203-share Restricted Stock Unit conversion reported in the Form 4.

What are the key details of the new Restricted Stock Unit grant to Steve E. Krognes at GH?

Krognes received 2,711 Restricted Stock Units on June 17, 2026. Each unit represents a right to receive one share of common stock, vesting fully on June 17, 2027 or the date of Guardant Health’s next annual stockholder meeting, whichever occurs first.

Did Steve E. Krognes buy or sell Guardant Health shares on the open market in this Form 4?

No open-market buys or sells were reported. The filing shows a derivative exercise of 4,203 Restricted Stock Units into common stock and a separate grant of 2,711 Restricted Stock Units, both categorized as acquisitions rather than market trades.

How do the vested Restricted Stock Units affect Guardant Health director Steve E. Krognes’s holdings?

When 4,203 Restricted Stock Units vested on June 17, 2026, they converted into 4,203 common shares, increasing Krognes’s direct stock holdings to 14,425 shares as reported in the Form 4 after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 05:53 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krognes Steve E.

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		M		4,203	A	$0	14,425	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	06/17/2026		M			4,203	(1)	(2)	Common Stock	4,203	$0	0	D
Restricted Stock Units	$0	06/17/2026		A		2,711		(3)	(2)	Common Stock	2,711	$0	2,711	D

Explanation of Responses:

1. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.

2. Not applicable for Restricted Stock Units.

3. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.

Remarks:

	/s/ John Saia, as attorney-in-fact for Steve Krognes	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)